financetom
Business
financetom
/
Business
/
Brazil sees 35.9% of exports to US facing steeper tariff, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Brazil sees 35.9% of exports to US facing steeper tariff, sources say
Jul 31, 2025 4:14 AM

BRASILIA (Reuters) -Brazil estimates that 35.9% of its exports to the United States, by value, will be hit by a steep 50% tariff under an executive order issued on Wednesday by the Trump administration, two sources familiar with the matter told Reuters.

According to the sources, who spoke on condition of anonymity, the Ministry of Development, Industry, Trade and Services, which is leading trade negotiations with the U.S., is expected to unveil the figure later in the day.

Trump slapped the 50% tariff to fight what he has called a "witch hunt" against former President Jair Bolsonaro, but softened the blow by excluding sectors such as aircraft, energy and orange juice from heavier levies.

The Brazilian government will also report that another 44.6% of local products will be subject to the preexisting 10% tariff, while the remaining 19.5% will fall under tariffs the U.S. applies globally, ranging from 25% to 50%, added the sources.

The MDIC did not immediately respond to a request for comment.

(Reporting by Marcela AyresEditing by Ros Russell)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Evotec Shares Rise Following Gene Therapy Exit, Q1 Results
Evotec Shares Rise Following Gene Therapy Exit, Q1 Results
May 22, 2024
02:24 PM EDT, 05/22/2024 (MT Newswires) -- Evotec (EVO) shares rose as much as 2.6% in recent Wednesday trading following the life science company's decision to shut down its gene therapy business in Austria. The company announced its gene therapy exit to sharpen focus on core modalities as it reported a wider net loss and lower revenue for the quarter...
FDA classifies recall of Hologic's implants for soft tissue as 'most serious'
FDA classifies recall of Hologic's implants for soft tissue as 'most serious'
May 22, 2024
May 22 (Reuters) - The U.S. Food and Drug Administration on Wednesday classified a recall of Hologic's ( HOLX ) devices that are implanted in soft tissue such as breast tissue as most serious. ...
Toll Brothers Shares Dip On Q2 Results Despite Earnings Beat
Toll Brothers Shares Dip On Q2 Results Despite Earnings Beat
May 22, 2024
Toll Brothers, Inc ( TOL ) shares experienced a decline Wednesday following the release of the company’s second-quarter 2024 financial results, despite reporting earnings that exceeded analyst expectations.  What To Know: The luxury homebuilder reported fiscal second-quarter EPS of $4.55, surpassing the consensus estimate of $4.06 by 12.07%. Quarterly sales came in at $2.837 billion, beating the estimate of $2.533...
Exxon Lawsuit Challenging Activist Investor's Climate Proposal to Proceed
Exxon Lawsuit Challenging Activist Investor's Climate Proposal to Proceed
May 22, 2024
02:27 PM EDT, 05/22/2024 (MT Newswires) -- Exxon Mobil's ( XOM ) lawsuit seeking a declaratory judgement that activist group Arjuna Capital's 2024 emissions-reduction proposal is excludable may proceed, a federal judge in Texas ruled Wednesday. The judge ruled in favor of Exxon even though Arjuna withdrew its proposal and submitted a letter stating it would never refile it after...
Copyright 2023-2026 - www.financetom.com All Rights Reserved